Summary
BioScrip Inc (BioScrip), formerly MIM Corp is a healthcare service provider that offers infusion care services. The hospital provides a range of infusion services, PBM services and respiratory services. Its infusion therapy services include antimicrobial drugs, factor replacement therapy for hemophilia, hepatitis therapy, biologic agents, monoclonal antibodies, inotropic therapy for late stage heart failure, pain management and other injectable therapies, among others. BioScrip also provides oxygen therapy, CPAP and Bi-level therapy, ventilator therapy and tracheostomy therapy equipment. The hospital has operations in Alabama, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Massachusetts, Maine, Minnesota, and North Carolina, among others. BioScrip is headquartered in Denver, Colorado, the US.
BioScrip Inc (BIOS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
BioScrip Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioScrip Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioScrip Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioScrip Inc, Medical Devices Deals, 2011 to YTD 2017 8
BioScrip Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
BioScrip Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Bioscrip Raises USD5 Million in Private Placement of Shares 10
BioScrip Raises USD1.1 Million in Rights Offering of Units 11
BioScrip Raises USD62.5 Million in Private Placement 12
BioScrip Completes Public Offering Of Common Stock For US$119 Million 13
Debt Offering 14
BioScrip Completes Private Placement Of Notes Due 2021 For US$200 Million 14
Asset Transactions 15
Walgreen Completes Acquisition Of Community Specialty Pharmacies And Centralized Specialty And Mail Service Pharmacy Businesses From BioScrip For Up To US$241 Million 15
Acquisition 16
LHC Group Completes Acquisition Of Deaconess HomeCare And Elk Valley Health Services From BioScrip For US$59.5 Million 16
BioScrip Completes Acquisition Of CarePoint Partners For US$223 Million 18
BioScrip Completes Acquisition Of HomeChoice Partners, Infusion Services Company, For US$70 Million 19
BioScrip Inc - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List of Tables
BioScrip Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
BioScrip Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 1
BioScrip Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioScrip Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BioScrip Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioScrip Inc, Medical Devices Deals, 2011 to YTD 2017 8
BioScrip Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bioscrip Raises USD5 Million in Private Placement of Shares 10
BioScrip Raises USD1.1 Million in Rights Offering of Units 11
BioScrip Raises USD62.5 Million in Private Placement 12
BioScrip Completes Public Offering Of Common Stock For US$119 Million 13
BioScrip Completes Private Placement Of Notes Due 2021 For US$200 Million 14
Walgreen Completes Acquisition Of Community Specialty Pharmacies And Centralized Specialty And Mail Service Pharmacy Businesses From BioScrip For Up To US$241 Million 15
LHC Group Completes Acquisition Of Deaconess HomeCare And Elk Valley Health Services From BioScrip For US$59.5 Million 16
BioScrip Completes Acquisition Of CarePoint Partners For US$223 Million 18
BioScrip Completes Acquisition Of HomeChoice Partners, Infusion Services Company, For US$70 Million 19
BioScrip Inc, Key Competitors 21
BioScrip Inc, Key Employees 22
BioScrip Inc, Other Locations 23
BioScrip Inc, Subsidiaries 24
List of Figures
BioScrip Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
BioScrip Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
BioScrip Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
BioScrip Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BioScrip Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
BioScrip Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BioScrip Inc, Medical Devices Deals, 2011 to YTD 2017 8